Back to search

University of West Attica

Διαχείριση ασθενών με χρόνια αναπνευστικά νοσήματα στα πλαίσια της πρωτοβάθμιας φροντίδας υγείας (Π.Φ.Υ.)

Abstract

dc:description

Introduction: Chronic respiratory diseases constitute a major and continuously growing global public health challenge, imposing substantial socioeconomic and psychosocial burdens. Asthma, one of the most prevalent chronic respiratory conditions, has significant effects on patients’ physical, psychological, and social functioning, thereby substantially influencing their overall quality of life. The early identification and effective support of individuals with asthma became particularly important during the COVID-19 pandemic, given the chronic nature of the disease and its impact across all age groups. In this context, Primary Health Care (PHC) plays a pivotal role in the management of patients with chronic respiratory diseases through prevention, early diagnosis, long-term follow-up, and the promotion of self-management, contributing to the improvement of Health-Related Quality of Life (HRQOL) and the sustainability of health systems. Aim: The Purpose of the present study is to highlight the role of Public Health, with particular emphasis on Primary Health Care (PHC), as a central pillar of social policy for improving the quality of life of patients with asthma and preventing disease exacerbations. The study investigates the pivotal role of PHC in the comprehensive management of asthma, focusing on early diagnosis, individualized therapeutic approaches, continuous monitoring, and patient education in self-management, particularly during public health crises. These interventions are examined in relation to their contribution to improving patients’ quality of life and reducing the economic burden associated with the disease. Furthermore, the study explores asthma self-management practices during the COVID-19 pandemic and assesses the related economic burden of the disease. In addition, it evaluates the quality of PHC services in terms of service provision, availability, and accessibility, as well as patients’ satisfaction with medical, nursing, and administrative services. Material and Method: The study was based on a primary cross-sectional follow-up cohort survey conducted by telephone during the COVID-19 pandemic among patients with asthma, who had previously been diagnosed and trained in asthma self-management within the framework of Primary Health Care (PHC). The study population consisted of patients who had attended the “Asthma School” at the Model Urban Health Centre of Peristeri during 2014–2015 and had received structured education from specialized personnel of the Hellenic Center for Disease Control and Prevention (HCDCP) of the Ministry of Health. A structured questionnaire was developed for data collection, including demographic and socioeconomic characteristics, daily dietary habits, and general lifestyle factors, as well as questions regarding asthma self-management during the previous five years and the last twelve months. Particular emphasis was placed on adherence to the Ministry of Health guidelines concerning the investigation and prevention of COVID-19 infection and their impact on participants’ quality of life. In addition, Health-Related Quality of Life (HRQoL) was assessed by examining all dimensions of the Asthma Quality of Life Questionnaire (AQLQ) and the Short Form Health Survey (SF-12), fear of COVID-19 was evaluated using the Fear of COVID-19 Scale (FCV-19S), while negative emotional states, including depression, anxiety, and stress, were assessed using the Depression Anxiety Stress Scales (DASS-21). Furthermore, asthma control and asthma symptom control were evaluated using the Asthma Control Test (ACT) and the Asthma Control Questionnaire (ACQ), respectively, while the perceived quality of PHC services provided was also assessed. Descriptive statistical analysis was performed. Independent-samples t-tests were conducted to examine differences in the total scores of the AQLQ, ACQ, and ACT scales, as well as in the four dimensions of the AQLQ (symptoms, activity limitation, emotional function, and environmental stimuli) according to dichotomous variables. Analysis of variance (ANOVA) was applied to investigate differences according to variables comprising more than two categories. Correlation analyses were also performed to examine the associations between the total scores of the scales and the dimensions of the AQLQ with the dimensions of other instruments, namely the FCV-19S, DASS-21, and SF-12 scales. Finally, linear regression analyses were conducted to investigate the effects of the study variables on the AQLQ, ACQ, and ACT scales, as well as on the four dimensions of the AQLQ. Results: A total of 112 patients participated in the study, of whom 70.5% were female and 29.5% were male, all of Greek nationality, with a mean age of 51.38±14.26 years. Statistically significant differences were observed across all three assessment scales (AQLQ, ACQ, and ACT; p<0.001) according to whether participants had visited the Emergency Department or had been hospitalized due to an asthma exacerbation, as well as according to the reported frequency of breathlessness during the previous five years. Patients who evaluated their asthma status as good reported significantly higher Quality of Life (QoL) scores (Mean=4.91), with significant differences observed between groups (p<0.001). Regarding the frequency of asthma exacerbations, statistically significant differences were also identified (p=0.004). Patients experiencing frequent asthma exacerbations reported lower QoL scores (Mean=3.34), whereas those reporting seasonal or infrequent exacerbations demonstrated higher QoL levels. The frequency of exacerbations was significantly associated with QoL and with self-reported COVID-19 infection (p=0.05). Statistically significant differences in the total scores of the AQLQ (p=0.013), ACQ (p=0.015), and ACT (p=0.009) were also observed according to smoking status. Pairwise comparisons revealed significant differences between non-smokers and former smokers, with non-smokers demonstrating better quality of life, superior asthma control, and higher asthma management scores. Following smoking cessation counseling provided by the Public Health Officer and recommendations from the pulmonologist, 45.5% of participants reported having quit smoking, whereas 30.3% continued to smoke regularly and 15.2% reported unsuccessful smoking cessation. According to ACT classification, 83.0% of participants exhibited uncontrolled asthma, while 17.0% demonstrated partially controlled asthma. No participant was classified as having fully controlled asthma. Comparison of ACT asthma control scores over time revealed a decline in asthma control, with the mean ACT score decreasing from 17.53±3.75 five years previously to 15.48±3.40 at the time of the study. Additional analyses demonstrated that unemployed participants reported significantly poorer quality of life, both in terms of the overall AQLQ score (p=0.005) and specifically in the symptoms domain of the AQLQ (p=0.047). Participants with higher educational attainment, particularly university graduates and holders of postgraduate degrees, exhibited better asthma control according to the ACQ (p<0.05). Furthermore, a statistically significant difference was observed in the emotional function domain of the AQLQ (p=0.005) in relation to the average monthly income, with significant differences identified between the income categories of €0–700 and €1,401–2,500. The total annual cost of asthma during the previous 12 months had a mean value of €312.79±139.724. Medical consultations and physician visits accounted for a mean cost of €91.79±79.596, medication-related expenses (patient co-payment) amounted to €211.8±77.678, while hospitalization and hospital-related costs averaged €9.2±41.852. The overall healthcare expenditure during the previous 12 months, including costs related to asthma and other health services, had a mean value of €493.87±251.485. Physician consultations and medical visits accounted for a mean cost of €156.16±152.53, including informal payments. Medication-related expenses amounted to €300.96±131.487, including patient co-payments, while hospitalization and hospital-related costs, including both public and private hospital services, averaged €36.74±108.799. Statistically significant differences were identified in the AQLQ activity limitation (p=0.021) and emotional function (p=0.029) domains according to participants’ compliance with the Ministry of Health guidelines for COVID-19 prevention. Better Health-Related Quality of Life (HRQoL) (p<0.01) was observed among males, younger patients, unmarried individuals, and students. Poor asthma control was associated with reduced work activity, increased breathlessness, more frequent nocturnal awakenings, greater use of inhalers or nebulizers, and higher levels of anxiety, stress, and depression (p<0.01). In turn, these psychological factors were significantly associated (p<0.01) with greater fear of COVID-19. This study demonstrated according to the World Health Organization (WHO) body mass index (BMI) classification, 38.4% of participants were overweight and 18.8% were classified as having Class I obesity. Furthermore, among patients with asthma belonging to vulnerable groups as defined by Government Gazette Issue (FEK) 1856/15-05-2020, 41.1% presented with elevated BMI, while 8.9% had uncontrolled diabetes mellitus. Participants classified as belonging to vulnerable groups exhibited significantly poorer quality of life according to the overall AQLQ score (p=0.002). Similarly, poorer quality of life was observed among patients with severe cardiovascular disease (p=0.043), resistant hypertension (p=0.015), uncontrolled diabetes mellitus (p<0.001), and elevated BMI (p=0.016). Worse asthma control, as assessed by the ACQ, was reported among participants belonging to vulnerable groups (p=0.008) and those with elevated BMI (p=0.016). In addition, poorer asthma control levels according to the ACT were observed among patients with resistant hypertension (p=0.023) and uncontrolled diabetes mellitus (p<0.020). Participants who had received medication for a respiratory tract infection during the previous 12 months reported significantly poorer quality of life according to the overall AQLQ score (p<0.001), poorer asthma control according to the ACQ (p<0.001), and lower asthma control levels according to the ACT (p<0.001). Moreover, they demonstrated significantly poorer outcomes across all AQLQ domains, including symptoms, activity limitation, emotional function, and environmental stimuli (p<0.01). The proportion of participants diagnosed with COVID-19 was 60.7% and exhibited poorer quality of life according to the overall AQLQ score. Participants who reported feeling ill during the previous 12 months, those who experienced fever >37.5°C (p=0.029), and those who reported cough during the same period demonstrated significantly poorer quality of life according to the overall AQLQ score (p=0.029). Similarly, poorer quality of life was observed among participants diagnosed with COVID-19 (p=0.050), those who had recovered from COVID-19 with a medical certificate of recovery (p=0.050), and those who had been in close contact with confirmed COVID-19 cases (p=0.037). Asthma patients who had been vaccinated against COVID-19 (94.6%, n=106) ex-hibited significantly better asthma control according to the ACT (p<0.05) compared with unvaccinated participants (n=6). In addition, influenza vaccination (65.2%, n=73) was associated with better asthma control according to the ACQ (p=0.05). In the present study, those who fully comply with the Ministry of Health's instructions for the prevention of COVID-19 in various activities have a better quality of life in terms of symptoms according to the AQLQ (p=0.044), better asthma control according to the ACQ (p=0.039), and better levels of asthma control according to the ACT (p=0.039), compared with those who reported only partial adherence. In addition, higher adherence to these guidelines was associated with better quality of life in the AQLQ domains of activity limitation (p=0.021) and emotional function (p=0.029). Additionally, more hours of mask use for protection against COVID-19, specifically > 4 hours daily, implies that asthma patients have a better quality of life according to the AQLQ dimension, which concerns activity limitation (p=0.042). The total ACQ score was significantly influenced by asthma-related hospitalization (B=0.520, p=0.003), satisfaction with daily life (B=0.151, p=0.019), use of medication for respiratory tract infections (B=−0.313, p<0.001), experience of breathing difficulties due to mask use (B=−0.287, p=0.003), physical health status (PCS) (B=−0.028, p=0.003), and fear of COVID-19 (B=−0.044, p=0.019). The adoption of a Mediterranean dietary pattern (B=0.340, p=0.015), absence of medication use for respiratory tract infections (B=0.329, p=0.002), and better physical health status (PCS) (B=0.036, p=0.001) were significantly associated with higher scores in the corresponding AQLQ subscale, indicating lower activity limitation. Additionally, it was observed, a positive and statistically significant correlation was observed between AQLQ scores (rho=0.200, p<0.05) and ACT scores (rho=0.187, p<0.05) in relation with overall satisfaction regarding medical and nursing care. Higher levels of healthcare satisfaction were associated with better asthma control and improved quality of life among patients with asthma.Conclusions: Asthma is a chronic disease associated with significant physical, psychosocial, and functional consequences, which become even more pronounced during the COVID-19 pandemic. The findings of this study highlight that demographic, behavioral, and healthcare-related factors, as well as comorbidities, have a substantial impact on the quality of life of patients with asthma. Patients’ quality of life is closely associated with the level of disease control, while self-management and support through Primary Health Care (PHC) contribute significantly to improved treatment adherence, reduced exacerbations, and lower healthcare costs. Health-Related Quality of Life (HRQoL) was found to be impaired, with the physical health dimension demonstrating lower scores than the mental health dimension across all patient groups. Continuous follow-up through specialized healthcare services in collaboration with PHC is considered essential for achieving optimal disease control. Furthermore, patient education enhances self-management skills and treatment adherence, reducing the need for emergency and secondary healthcare services and consequently limiting the overall economic burden of the disease. Asthma exacerbations are associated with considerable social, psychological, and healthcare-related costs. The cost of asthma is in-creasing as disease control decreases and significant cost savings could be achieved through the proper management of patients with asthma, strengthening the relationship between Public Health and Public Policy. Targeted education of patients with asthma is important in primary health care and can lead to better patient compliance and greater treatment effectiveness. During the pandemic period, telephone-based support proved to be a particularly valuable complementary tool for patient monitoring and follow-up. In conclusion, the find-ings of this study highlight the pivotal role of a holistic approach to asthma management within the framework of strengthening Primary Health Care (PHC). At the same time, they underscore the need for the promotion of patients’ health enhancement and the development of comprehensive strategies that incorporate targeted public health interventions which can strengthen social policies by contributing to the organization and safeguarding of equity, universality, and solidarity regarding patients’ access to health and welfare services. Finally, the findings emphasize the importance of implementing evidence-based policies and interventions aimed at improving patients’ quality of life and overall health outcome.

Degree

thesis:*
Grantor dc:publisher
University of West Attica
Year dc:date
2026

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Stamatopoulou, Eleni
  • Σταματοπούλου, Ελένη

Subjects

dc:subject × 49

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/61880

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Stamatopoulou, Eleni; Σταματοπούλου, Ελένη. Διαχείριση ασθενών με χρόνια αναπνευστικά νοσήματα στα πλαίσια της πρωτοβάθμιας φροντίδας υγείας (Π.Φ.Υ.). University of West Attica, 2026. http://hdl.handle.net/10442/hedi/61880